04 Jun 2020 | 7:23 AM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
358.80
6.95
(1.98 %)
17 Jan 2020 | 10:51 AM
Change company
  • Open (Rs)
    351.70
  • Prev. close (Rs.)
    351.85
  • High (Rs.)
    365.15
  • Low (Rs.)
    350.55
  • 52W H (Rs.)
    554.00
  • 52W L (Rs.)
    267.30
  • Volume
    145803
  • MCap (Rs in Cr.)
    10,124.19
651.6
12.15
(1.90 %)
  • Open (Rs)
    640.05
  • High (Rs)
    652.50
  • Low (Rs)
    639.00
  • Prev. close(Rs)
    639.45
  • Contracts Tra.
    14,10,000
  • Turnover (Cr.)
    91
  • Open Interest
    9,00,000
  • Open Int. chg
    -9,40,000.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
32.78
Operating Margin (%)
16.07
Gross Profit Margin (%)
12.77
Net Profit Margin (%)
9.37
Total Debt/Equity
0.69
Dividend payout Ratio (Net Profit)
7.35
Earning Retention Ratio
91.03

News

14 Jan 2020 - 11:31:00-As of December 2019 46.59% is owned by Indian Promoters and 53.41% by Public...
08 Jan 2020 - 10:43:00-Glenmark Pharmaceuticals on Tuesday said it has got final approval from the US health regulator for ...
23 Dec 2019 - 10:28:00-Drug firm Glenmark Pharmaceutical Inc USA said it is voluntarily recalling all unexpired lots of its...
20 Dec 2019 - 11:38:00-Drug maker Glenmark Pharmaceuticals on Friday said that it has received approval from Australian reg...

Announcements

14-Jan-2020
Glenmark Pharma - Updates
14-Jan-2020
Glenmark Pharma - Re: Intimation Under The Securities And Exchange Board Of India (Listing Obligations And Disclosure Require
07-Jan-2020
Glenmark Pharma - Press Release
07-Jan-2020
Glenmark Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
20-Dec-2019
Glenmark Pharma - Press Release

Religare Research

28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 72.32 -0.48
10,00,000 115.06 58.72 -0.48
10,00,000 115.06 219.17 -0.48
10,00,000 115.06 233.16 -0.47
10,00,000 115.06 78.14 -0.47

Shareholding Pattern

       
Promotors46.58%
Mutual Funds/UTI4.31%
FI/Banks3.12%
Insurance3.12%
FII31.37%
Government0.00%
Others4.89%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
12,714.30(0.75)
3280
 Sanofi India Ltd.
6,732.20(0.17)
3325
 Pfizer Ltd.
4,045.60(-0.07)
3370
 Dr. Reddy`s Laboratories Ltd.
2,969.40(1.08)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.26.7533.50-82.45
NIFTY(S&P CNX)304.15877.90486.75
BSE SENSEX1,143.203,278.042,258.87
BSE 500517.641,252.93682.71

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Ind. Non-Executive Director
Brian W Tempest
Ind. Non-Executive Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

csr@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
KFIN Technologies Pvt. Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda Serilingampally Mandal